908 Devices

Develops handheld and desktop analytical instruments

Broadway, Virginia, United States

About 908 Devices

908 Devices specializes in chemical and biochemical analysis, providing solutions for life science research, biopharmaceuticals, and forensics. Their products, including handheld and desktop devices like the REBEL and ZipChip, deliver rapid and accurate data, enabling users to make informed decisions quickly. The REBEL device allows for instant amino acid profiling, while the ZipChip enhances sample preparation for metabolomic and proteomic analyses. Unlike competitors, 908 Devices focuses on simplifying complex analyses, which helps clients reduce time-to-results and improve data accuracy. The company's goal is to enhance the efficiency of analytical processes across various industries, ultimately providing significant value to their clients.

Broadway, VirginiaHeadquarters
2012Year Founded
$65MTotal Funding
IPOCompany Stage
Industrial & Manufacturing, Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Flexible Work Hours
Remote Work Options

Risks

Emerging competitors may impact 908 Devices' market share.
Technical challenges with RedWave integration could delay product rollouts.
Supply chain disruptions may lead to production delays and increased costs.

Differentiation

908 Devices offers handheld mass spectrometry tools exceeding military standards.
Their products provide rapid, accurate data crucial for critical applications.
The acquisition of RedWave Technology expands their forensic product offerings.

Upsides

Increased demand for portable devices boosts 908 Devices' market potential.
AI integration enhances data analysis, benefiting biochemical applications.
Miniaturization trends align with 908 Devices' focus on compact solutions.

Funding

Total raised$64.98 M
Latest valuation$87.50 M
StageIPO